Pletaal 50 Mg 20 Tablets

Pletaal 50 Mg 20 Tablets

Description:

Pletaal 50 mg is a prescription oral medicine containing cilostazol, a phosphodiesterase type III (PDE3) inhibitor used to improve blood flow in patients with peripheral arterial disease. It is primarily indicated for the relief of intermittent claudication symptoms, such as leg pain and cramping during walking, by promoting vasodilation and inhibiting platelet aggregation. Manufactured by Otsuka, Pletaal helps increase walking distance and functional capacity in adults with peripheral vascular disease as part of a comprehensive cardiovascular risk management plan.

Indications:

• Symptomatic treatment of intermittent claudication due to peripheral arterial disease (PAD) in adults.
• Improves walking distance and reduces leg pain and cramping induced by exercise in patients with peripheral vascular disease.
• Used as part of a broader cardiovascular risk reduction strategy, including smoking cessation, exercise, and control of blood pressure and lipids, as directed by a physician.

Active Ingredients / Key Components:

• Cilostazol – 50 mg per tablet.
• Excipients: Full list of inactive ingredients (e.g., fillers, binders, colorants, preservatives) is not available in the provided information. Please refer to the official package leaflet for a complete excipient list.

Dosage & Administration / How to Use:

• Usual adult dose (as commonly referenced for cilostazol): 100 mg per day given as 50 mg twice daily, or as directed by the prescribing physician. Always follow your doctor’s exact instructions.
• Take tablets orally with a glass of water.
• Generally recommended to be taken at least 30 minutes before or 2 hours after breakfast and dinner to optimize absorption, unless your doctor advises otherwise.
• Do not crush or chew the tablets; swallow whole.
• Duration of treatment: Clinical benefit may appear after several weeks; your doctor will periodically reassess the need for continued therapy.
• If you miss a dose, take it as soon as you remember unless it is almost time for the next dose. Do not double the dose to make up for a missed one.
• Use only under medical supervision and do not adjust the dose without consulting your physician.

Clinical Benefits:

• Improves peripheral blood flow by causing vasodilation of blood vessels in the legs.
• Inhibits platelet aggregation, helping to reduce blood clot formation and improve circulation.
• Increases pain-free walking distance in patients with intermittent claudication.
• Helps reduce frequency and severity of exercise-induced leg pain and cramping associated with peripheral arterial disease.

Warnings & Contraindications:

• Contraindicated in patients with any degree of congestive heart failure due to increased mortality seen with drugs of this class (PDE3 inhibitors).
• Contraindicated in patients with known hypersensitivity to cilostazol or any component of the formulation.
• Use with caution in patients with a history of bleeding disorders, active peptic ulcer, recent stroke, recent myocardial infarction, or severe hypertension; bleeding risk may be increased.
• Use with caution in patients with moderate to severe hepatic or renal impairment; dose adjustment or alternative therapy may be required as per physician judgment.
• May interact with other medications such as anticoagulants, antiplatelet agents (e.g., aspirin, clopidogrel), CYP3A4 or CYP2C19 inhibitors/inducers (e.g., some antifungals, macrolide antibiotics, proton pump inhibitors). Inform your doctor about all medicines and supplements you are taking.
• May cause dizziness or headache; caution is advised when driving or operating machinery until you know how the medicine affects you.
• Consult your doctor before use if pregnant, planning pregnancy, or nursing. Cilostazol is generally not recommended during pregnancy or breastfeeding unless clearly needed and prescribed by a physician.
• Consult your doctor before use if you have heart disease, arrhythmias, history of stroke, bleeding disorders, liver disease, kidney disease, diabetes, or if you are taking blood thinners.
• Not intended to diagnose, treat, cure, or prevent any disease without proper medical supervision.
• Keep out of reach of children.

Side Effects:

• Common side effects may include headache, dizziness, palpitations, tachycardia (fast heartbeat), diarrhea, abdominal pain, nausea, vomiting, indigestion, and peripheral edema (swelling of ankles or feet).
• Less common side effects may include rash, pruritus (itching), bruising, nosebleeds, or increased tendency to bleed.
• Serious side effects (seek immediate medical attention): signs of severe bleeding (such as blood in stool or urine, vomiting blood, unusual bruising), chest pain, severe or irregular heartbeat, shortness of breath, signs of stroke (sudden weakness, difficulty speaking, vision changes), or severe allergic reactions (swelling of face, lips, tongue, or throat; difficulty breathing).
• If you experience any persistent, bothersome, or unexpected side effects, contact your doctor or pharmacist promptly.

Storage Instructions:

Store in a cool, dry place away from direct sunlight. Keep container tightly closed. Keep out of reach of children.

Specifications:

• Product type: Prescription medicine for peripheral arterial disease.
• Active ingredient strength: cilostazol 50 mg per tablet.
• Form: Oral tablet.
• Pack size: 20 tablets per pack.
• Intended use: Adults with intermittent claudication due to peripheral arterial disease, under medical supervision.

Disclaimer:
All pharmacy products are intended for general use only and do not replace professional medical advice, diagnosis, or treatment. Always consult a healthcare provider before use. Results may vary, and no specific outcomes are guaranteed. Products are not intended to diagnose, treat, cure, or prevent any disease unless stated. Follow label instructions carefully, as misuse may cause adverse effects. Compliance with local laws is the customer’s responsibility.